Product image of Nhytideta (Ethinylestradiol, Gestodene) supplied by GNH India

Nhytideta

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Nhytideta (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Nhytideta, is a combined oral contraceptive presented as a tablet for oral use. It works together with gestodene to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH India supplies Nhytideta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistical support for global healthcare providers.

Manufacturer / TM Owner

Laboratorios León Farma, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nhytideta is a combined oral contraceptive that acts on the hypothalamic‑pituitary‑gonadal axis to prevent pregnancy and can be used for related menstrual indications.

  • Pregnancy prevention: provides reliable contraception for women of child‑bearing potential.
  • Menstrual cycle regulation: helps establish regular menstrual bleeding patterns.
  • Acne treatment: may improve mild to moderate acne associated with hormonal fluctuations.

How It Works

  • Ethinylestradiol and gestodene combine to suppress the hypothalamic‑pituitary‑gonadal axis, reducing the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). This inhibition prevents follicular development and ovulation. In addition, the estrogen component stabilises the endometrial lining while the progestin component thickens cervical mucus and alters the endometrium, creating an environment hostile to fertilisation and implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: transient swelling or discomfort.
  • Spotting: irregular breakthrough bleeding.
  • Weight fluctuation: mild fluid retention.
  • Mood changes: irritability or mild depression.

Serious or Rare Side Effects

  • Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
  • Arterial thrombosis: stroke or myocardial infarction.
  • Hypertension: sudden increase in blood pressure.
  • Liver dysfunction: jaundice or hepatic adenoma.
  • Gallbladder disease: cholelithiasis or biliary colic.
  • Severe allergic reaction: anaphylaxis or angioedema.

Precautions & Warnings

Before starting Nhytideta, consider the following precautions:

  • Contraindications: do not use in women with known thromboembolic disorders, active liver disease, or hormone‑sensitive cancers.
  • Smoking: avoid use if over 35 years old and a smoker, due to increased cardiovascular risk.
  • Cardiovascular risk: assess blood pressure and lipid profile regularly.
  • Migraine history: caution in patients with migraine with aura.
  • Pregnancy category: classified as Category X; must not be used during pregnancy.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nhytideta may interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): may reduce efficacy of oral contraceptives.
  • Certain antiretrovirals (e.g., efavirenz): can lower hormone levels, risking contraceptive failure.
  • Enzyme inducers (e.g., rifampicin, carbamazepine): markedly increase metabolism of ethinylestradiol and gestodene.

Moderate Interactions (Monitor Closely)

  • Antifungals (e.g., ketoconazole): may increase hormone concentrations, raising side‑effect risk.
  • Antidepressants (e.g., sertraline): occasional alterations in hormone levels.
  • Herbal supplements (e.g., St. John’s wort): may modestly reduce contraceptive effectiveness.
  • Diuretics: can affect fluid balance and blood pressure, requiring monitoring.

Frequently Asked Questions

Nhytideta is a combined oral contraceptive containing ethinylestradiol and gestodene. It is prescribed to prevent pregnancy in women of reproductive age and may also be used to regulate menstrual cycles or treat mild hormonal acne.

Ethinylestradiol, together with gestodene, suppresses the hypothalamic‑pituitary‑gonadal axis, lowering LH and FSH release. This blocks ovulation, thickens cervical mucus, and alters the endometrial lining, creating conditions that prevent fertilisation and implantation.

The specific dosing regimen for Nhytideta is determined by the prescribing healthcare professional. Typically, combined oral contraceptives are taken once daily for a defined cycle, but the exact schedule should follow the prescriber’s instructions.

Nhytideta is classified as Pregnancy Category X, meaning it must not be used during pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding unless the benefits outweigh risks, and a healthcare provider should be consulted.

To order Nhytideta, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nhytideta contains the progestin gestodene, which is considered a third‑generation agent associated with a lower risk of androgenic side effects compared with older progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly.

Store Nhytideta at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Nhytideta is taken orally, usually as a tablet taken at the same time each day. The regimen typically follows a 21‑day active tablet sequence followed by a hormone‑free interval, but patients should follow the schedule prescribed by their healthcare professional.

The most serious risks include venous thromboembolism, arterial thrombosis (such as stroke or myocardial infarction), severe hypertension, and liver disorders. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid use.

Nhytideta should not be used by women with known thromboembolic disease, active liver disease, hormone‑sensitive cancers, uncontrolled hypertension, or those who are pregnant. It is also contraindicated in smokers over 35 years of age and in individuals with a history of migraine with aura.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT